Novel flavonoids with antiproliferative activities against breast cancer cells

Nianhuan Yao, Chao Yu Chen, Chun Yi Wu, Kiyomi Motonishi, Hsing-Jien Kung, Kit Lam

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

Original languageEnglish (US)
Pages (from-to)4339-4349
Number of pages11
JournalJournal of Medicinal Chemistry
Volume54
Issue number13
DOIs
StatePublished - Jul 14 2011

Fingerprint

flavone
Flavonoids
Bacteriophages
Inhibitory Concentration 50
Breast Neoplasms
Proteome
DNA Sequence Analysis
Complementary DNA
Proteins
Therapeutics
Lead
N-dodecyl-L-lysine amide

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Novel flavonoids with antiproliferative activities against breast cancer cells. / Yao, Nianhuan; Chen, Chao Yu; Wu, Chun Yi; Motonishi, Kiyomi; Kung, Hsing-Jien; Lam, Kit.

In: Journal of Medicinal Chemistry, Vol. 54, No. 13, 14.07.2011, p. 4339-4349.

Research output: Contribution to journalArticle

Yao, Nianhuan ; Chen, Chao Yu ; Wu, Chun Yi ; Motonishi, Kiyomi ; Kung, Hsing-Jien ; Lam, Kit. / Novel flavonoids with antiproliferative activities against breast cancer cells. In: Journal of Medicinal Chemistry. 2011 ; Vol. 54, No. 13. pp. 4339-4349.
@article{fec21078d790451590e34ef019c1956e,
title = "Novel flavonoids with antiproliferative activities against breast cancer cells",
abstract = "A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.",
author = "Nianhuan Yao and Chen, {Chao Yu} and Wu, {Chun Yi} and Kiyomi Motonishi and Hsing-Jien Kung and Kit Lam",
year = "2011",
month = "7",
day = "14",
doi = "10.1021/jm101440r",
language = "English (US)",
volume = "54",
pages = "4339--4349",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Novel flavonoids with antiproliferative activities against breast cancer cells

AU - Yao, Nianhuan

AU - Chen, Chao Yu

AU - Wu, Chun Yi

AU - Motonishi, Kiyomi

AU - Kung, Hsing-Jien

AU - Lam, Kit

PY - 2011/7/14

Y1 - 2011/7/14

N2 - A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

AB - A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

UR - http://www.scopus.com/inward/record.url?scp=79960182468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960182468&partnerID=8YFLogxK

U2 - 10.1021/jm101440r

DO - 10.1021/jm101440r

M3 - Article

C2 - 21599001

AN - SCOPUS:79960182468

VL - 54

SP - 4339

EP - 4349

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -